New CIOMS Working Group on Vaccine Safety
The new CIOMS Working Group on Vaccine Safety has been established in 2013 to address one strategic objective of the Global Vaccine Safety Blueprint “To put in place systems for appropriate interaction between national governments, multilateral agencies, and manufacturers at national, regional and international levels “.
The group is composed of representatives from regulatory and public health agencies, manufacturers, academia and technical agencies. It plans on meeting two times per year. During its second meeting on 18-19 September 2013 in Geneva, the working group consolidated the topics of interest identified during the first meeting. Several cross-sectorial teams were formed to develop those respective areas.
The expected outcomes of this working group is to produce a series of consensus publications.
In light of the upcoming GVSI meeting in November, the 3rd GVSI bulletin is now available online. It includes a progress report on vaccine safety activities in the Americas, summaries of two GVSI stakeholders’ activities, introduces the chair of the GVSI Planning Group, and provides an update on the Multi Country Collaboration project.
Revised aide-mémoire on assessing causality after AEFI
In July 2013, a user manual using the revised WHO causality assessment methodology was published and is currently available online. This aide-mémoire is a synopsis of the revised methodology that complements the user manual and replaces the previous aide-mémoire. It provides the assessor an outline of the new causality assessment process to enable the classification of individual AEFI cases in a standardized, transparent manner so that health officials at all levels are able to respond to vaccine safety alerts logically and scientifically.
People are concerned about vaccinations, especially when it is their own child who must be vaccinated. All health-care workers giving vaccines have a responsibility to listen to and try to understand a patient's concerns, fears, and beliefs about vaccination and to take them into consideration when offering vaccines. These efforts will not only help to strengthen the bond of trust between staff and patient but will also help determine which, if any, arguments might be most effective in persuading these patients to accept vaccination.
The Q&A addresses common misconceptions and provide suggestions to respond to these.
- The Global Vaccine Safety Initiative (GVSI)
- Global Vaccine Safety Blueprint
- Strategic Advisory Group of Experts (SAGE) on Immunization
- The Decade of Vaccine - Global Vaccine Action Plan
- Global Vaccine Safety Blueprint - landscape analysis
Global Vaccine Safety initiative activities portfolio 2012-2020